1. Analysis of predictors of response to ruxolitinib in patients with myelofibrosis in the phase 3b expanded-access JUMP study. Issue 4 (21st March 2021) Authors: Gupta, Vikas; Griesshammer, Martin; Martino, Bruno; Foltz, Lynda; Tavares, Renato; Al-Ali, Haifa Kathrin; Giraldo, Pilar; Guglielmelli, Paola; Lomaia, Elza; Bouard, Catherine; Paley, Carole; Tiwari, Ranjan; Zor, Evren; Raanani, Pia Journal: Leukemia & lymphoma Issue: Volume 62:Issue 4(2021) Page Start: 918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES study. Issue 3 (June 2019) Authors: Ho, P. Joy; Hiwase, Devendra; Ramakrishna, Raj; Viiala, Nicholas; Solterbeck, Ann; Traficante, Robert; Zor, Evren; Gervasio, Othon L.; High, Laura M.; Ross, David M.; Bowden, Donald K. Journal: HemaSphere Issue: Volume 3:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. RTID-05. TRIAL IN PROGRESS: DOSE-FINDING STUDY AND EVALUATION OF [177LU]LU-DOTA-TATE IN COMBINATION WITH STANDARD OF CARE IN NEWLY DIAGNOSED GLIOBLASTOMA AND AS A SINGLE AGENT IN RECURRENT GLIOBLASTOMA. (14th November 2022) Authors: Wen, Patrick Y; Cloughesy, Timothy; Demange, Arnaud; Herrmann, Ken; Weller, Michael; Zor, Evren Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ruxolitinib versus best available therapy in inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): 5-year follow up of a randomised, phase 3b study. Issue 7 (July 2022) Authors: Passamonti, Francesco; Palandri, Francesca; Saydam, Guray; Callum, Jeannie; Devos, Timothy; Guglielmelli, Paola; Vannucchi, Alessandro M; Zor, Evren; Zuurman, Mike; Gilotti, Geralyn; Zhang, Yifan; Griesshammer, Martin Journal: Lancet Issue: Volume 9:Issue 7(2022) Page Start: e480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗